Literature DB >> 22059157

Helicobacter pylori treatment in the hospital setting: a potential model for developing quality improvement initiatives to prevent missed test results.

Nicola Jones.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22059157      PMCID： PMC3206556          DOI： 10.1155/2011/781514

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


× No keyword cloud information.
  6 in total

1.  Antibiotic overuse: Stop the killing of beneficial bacteria.

Authors:  Martin Blaser
Journal:  Nature       Date:  2011-08-24       Impact factor: 49.962

2.  How well is Helicobacter pylori treated in usual practice?

Authors:  Kumaresan Yogeswaran; Grant Chen; Lawrence Cohen; Mary Anne Cooper; Elaine Yong; Eugene Hsieh; Corwyn Rowsell; Fred Saibil; Jill Tinmouth
Journal:  Can J Gastroenterol       Date:  2011-10       Impact factor: 3.522

Review 3.  Helicobacter pylori: gastric cancer and beyond.

Authors:  D Brent Polk; Richard M Peek
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

4.  Patient safety concerns arising from test results that return after hospital discharge.

Authors:  Christopher L Roy; Eric G Poon; Andrew S Karson; Zahra Ladak-Merchant; Robin E Johnson; Saverio M Maviglia; Tejal K Gandhi
Journal:  Ann Intern Med       Date:  2005-07-19       Impact factor: 25.391

5.  Is Helicobacter pylori being treated appropriately? A study of inpatients and outpatients in a tertiary care centre.

Authors:  Jose Nazareno; David K Driman; Paul Adams
Journal:  Can J Gastroenterol       Date:  2007-05       Impact factor: 3.522

Review 6.  The safety implications of missed test results for hospitalised patients: a systematic review.

Authors:  Joanne Callen; Andrew Georgiou; Julie Li; Johanna I Westbrook
Journal:  BMJ Qual Saf       Date:  2011-02-07       Impact factor: 7.035
  6 in total
  1 in total

1.  Patient Preferences for Test Result Notification.

Authors:  Samuel K Shultz; Robert Wu; John J Matelski; Xin Lu; Peter Cram
Journal:  J Gen Intern Med       Date:  2015-11       Impact factor: 5.128
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.